Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission-Reference-Cited by-同舟云学术

Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission

Published:2017-10-18 Issue:7 Volume:59 Page:1652-1658
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Li Wei-Yang¹²³,Wang Ying¹²³,Chen Su-Ning¹²³,Qiu Hui-Ying¹²³,Fu Zheng-Zheng¹²³,Wu De-Pei¹²³,Sun Ai-Ning¹²³

Affiliation:

1. Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China;

2. Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China;

3. Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1390235

Reference32 articles.

1. Cancer statistics, 2014

2. Acute myeloid leukemia in the real world: why population-based registries are needed

3. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

4. Age and acute myeloid leukemia

5. High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atelier d’harmonisations 2019 : indications et organisation d’une microtransplantation de cellules souches hématopoïétiques;Bulletin du Cancer;2020-12

2. Microtransplantation for Acute Myeloid Leukemia;JAMA Oncology;2020-10-01

3. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center;Stem Cell Research & Therapy;2020-07-01

4. Clinical efficacy of decitabine‑containing induction chemotherapy in de�novo non‑elderly acute myeloid leukemia;International Journal of Oncology;2020-03-30

5. Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study;BMC Cancer;2019-08-20